MedTrace Logo

Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function

NCT00173290 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2008-06-03

No results posted yet for this study

Summary

In this study proposal, the investigators will extend their previous studies and examine the kinetic cytotoxic activity with concordant expression of inhibitory natural killer (NK) receptors (iNKR) on activated T cells. The inhibitory role of cytokines will be defined by utilizing the investigators' previously established models of mixed lymphocytes and tumor cells coculture to analyze the expression and activity of cytokines involved in the regulation of iNKRs on cancer-encountered T cells.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Bor-Ching Sheu, MD, PhD · Department of Obstetrics and Gynecology, National Taiwan University Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-07-31
Completion
2006-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00173290 on ClinicalTrials.gov